XML 60 R44.htm IDEA: XBRL DOCUMENT  v2.3.0.11
Stock-Based Compensation Outstanding Options and SSARs (Details) (USD $)
In Millions, except Share data, unless otherwise specified
6 Months Ended
Jun. 30, 2011
years
Dec. 31, 2010
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested [Roll Forward]    
Beginning balance 7,580,000  
Incentive shares granted 813,000  
Options / SSARs exercised (18,000)  
Options / SSARs cancelled (47,000)  
Ending balance 8,328,000  
Options / SSARs outstanding Weighted Average Exercise Price $ 12.82 $ 13.10
SSARs granted Weighted Average Exercise Price $ 10.12  
Options / SSARs exercised Weighted Average Exercise Price $ 4.93  
Options / SSARs cancelled Weighted Average Exercise Price $ 14.14  
Options / SSARs outstanding Weighted Average Contractual Term (in years) 6.8  
Options / SSARs outstanding Aggregate Intrinsic Value (in millions) $ 12.0  
Vested and expected to vest 7,912,000  
Vested and expected to vest Aggregate Intrinsic Value (in millions) 11.4  
Options / SSARs exercisable 6,136,000  
Options / SSARs exercisable Weighted Average Exercise Price $ 14.96  
Options / SSARs exercisable Aggregate Intrinsic Value (in millions) 7.5  
Stock Options [Member] | Director [Member]
   
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested [Roll Forward]    
Number of months for options to vest at an incremental rate of ten percent for directors 3 months  
Options and SSARs [Member]
   
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested [Roll Forward]    
Weighted-average period of years costs are expected to be recognied over 1.7  
Compensation expense related to award 2.7  
Unrecognized compensation costs $ 1.5  
Shares available under stock award plans 4,715,177  
Stock Appreciation Rights (SARs) [Member]
   
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested [Roll Forward]    
Years SSARs become ratably exercisable over 3 years  
Years until SSARs expire P10Y  
Director [Member]
   
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested [Roll Forward]    
Starting Term When Options Become Exercisable After Grant Date 3 months